CANTEL MEDICAL CORP. (NYSE:CMD) Files An 8-K Results of Operations and Financial Condition

ME Staff 8-k
-
0
CANTEL MEDICAL CORP. (NYSE:CMD) Files An 8-K Results of Operations and Financial Condition

CANTEL MEDICAL CORP. (NYSE:CMD) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition

On November29, 2018, the Registrant issued a press release announcing its results of operations for the quarter ended October31, 2018 (Registrant’s first quarter of fiscal year 2019). A copy of the press release is included with this Report as Exhibit99.1.

Item 9.01 Financial Statements, Pro-Forma Financial Information and Exhibits

(d)Exhibit99.1 Press release of Registrant dated November29, 2018.


CANTEL MEDICAL CORP Exhibit
EX-99.1 2 cantelfy19q1ex991.htm EXHIBIT 99.1 Exhibit Exhibit 99.1  Cantel Medical Reports Financial Results for its First Quarter Fiscal Year 2019 Medical segment leads with strong double-digit growth•Net sales of $225.6M,…
To view the full exhibit click here

About CANTEL MEDICAL CORP. (NYSE:CMD)

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies. The Company’s Water Purification and Filtration segment includes water purification equipment and services, filtration and separation products, and disinfectant, sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use, infection prevention and control healthcare products. The Company’s Dialysis segment includes medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. The Company offers a range of filters utilizing hollow fiber membrane technology.